Cryo-Cell International (NYSEAMERICAN:CCEL) Stock Passes Below 200-Day Moving Average – What’s Next?

Cryo-Cell International Inc. (NYSEAMERICAN:CCEL) shares passed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $3.72 and traded as low as $3.41. Cryo-Cell International shares last traded at $3.56, with a volume of 10,098 shares.

Cryo-Cell International Stock Performance

The firm has a market capitalization of $28.69 million, a PE ratio of -10.79 and a beta of 0.54. The company has a fifty day moving average price of $3.35 and a 200-day moving average price of $3.72.

Cryo-Cell International (NYSEAMERICAN:CCEL) last issued its quarterly earnings data on Friday, February 27th. The company reported ($0.47) earnings per share (EPS) for the quarter. The firm had revenue of $7.84 million during the quarter.

Institutional Trading of Cryo-Cell International

A hedge fund recently bought a new stake in Cryo-Cell International stock. Susquehanna International Group LLP purchased a new stake in shares of Cryo-Cell International Inc. (NYSEAMERICAN:CCEL) during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 11,062 shares of the company’s stock, valued at approximately $51,000. Susquehanna International Group LLP owned 0.14% of Cryo-Cell International as of its most recent filing with the SEC. Institutional investors and hedge funds own 10.44% of the company’s stock.

About Cryo-Cell International

Cryo-Cell International, Inc is a pioneering provider of umbilical cord blood and tissue preservation services. Headquartered in Oldsmar, Florida, the company was founded in 1989 as the first private cord blood bank in the United States. Cryo-Cell operates FDA-registered and AABB-accredited laboratory facilities, maintaining stringent quality control measures and cryogenic storage systems to safeguard stem cell viability over long-term storage periods.

The company’s primary business activity centers on the collection, processing and secure storage of newborn stem cell sources harvested at birth.